TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE(-/-) Mice

Por Cartland, Siân P., Erlich, Jonathan H., Kavurma, Mary M.
Publicado em 2014

NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease

Por Manuneedhi Cholan, Pradeep, Cartland, Siân P., Kavurma, Mary M.
Publicado no Antioxidants (Basel) (2017)

Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo

Por Cartland, Siân P., Genner, Scott W., Zahoor, Amna, Kavurma, Mary M.
Publicado no Int J Mol Sci (2016)

Caveolin-1-Mediated Apolipoprotein A-I Membrane Binding Sites Are Not Required for Cholesterol Efflux

Por Le Lay, Soazig, Rodriguez, Macarena, Jessup, Wendy, Rentero, Carles, Li, Qiong, Cartland, Siân, Grewal, Thomas, Gaus, Katharina
Publicado em 2011

Chemokine binding protein ‘M3’ limits atherosclerosis in apolipoprotein E(-/-) mice

Por Ravindran, Dhanya, Ridiandries, Anisyah, Vanags, Laura Z., Henriquez, Rodney, Cartland, Siân, Tan, Joanne T. M., Bursill, Christina A.
Publicado no PLoS One (2017)

TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL

Por Di Bartolo, Belinda A., Cartland, Siân P., Harith, Hanis H., Bobryshev, Yuri V., Schoppet, Michael, Kavurma, Mary M.
Publicado em 2013

Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL

Por Di Bartolo, Belinda A., Cartland, Siân P., Harith, Hanis H., Bobryshev, Yuri V., Schoppet, Michael, Kavurma, Mary M.
Publicado em 2013

Cholesterol through the Looking Glass: ABILITY OF ITS ENANTIOMER ALSO TO ELICIT HOMEOSTATIC RESPONSES

Por Kristiana, Ika, Luu, Winnie, Stevenson, Julian, Cartland, Sian, Jessup, Wendy, Belani, Jitendra D., Rychnovsky, Scott D., Brown, Andrew J.
Publicado em 2012

Caveolin-1-dependent and -independent membrane domains

Por Le Lay, Soazig, Li, Qiong, Proschogo, Nicholas, Rodriguez, Macarena, Gunaratnam, Krishanthi, Cartland, Siân, Rentero, Carles, Jessup, Wendy, Mitchell, Todd, Gaus, Katharina
Publicado em 2009

Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice

Por Cartland, Siân P., Harith, Hanis H., Genner, Scott W., Dang, Lei, Cogger, Victoria C., Vellozzi, Melissa, Di Bartolo, Belinda A., Thomas, Shane R., Adams, Leon A., Kavurma, Mary M.
Publicado no Sci Rep (2017)

Tumor Necrosis Factor–Related Apoptosis‐Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia‐Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide–Dependent...

Por Di Bartolo, Belinda Ann, Cartland, Siân Peta, Prado‐Lourenco, Leonel, Griffith, Thomas Scott, Gentile, Carmine, Ravindran, Jayant, Azahri, Nor Saadah Muhammad, Thai, Thuan, Yeung, Amanda Wing Shee, Thomas, Shane Ross, Kavurma, Mary Meltem
Publicado no J Am Heart Assoc (2015)